- Stocks
- Healthcare
- NYSE: LLY

Price (delayed)

$237.88

Market cap

$227.55B

P/E Ratio

35.61

Dividend/share

$3.29

EPS

$6.68

Enterprise value

$240.85B

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded

ELI LILLY's revenue has increased by 16% YoY and by 4.9% from the previous quarter

The company's gross profit rose by 10% YoY and by 2.6% QoQ

The equity has surged by 57% year-on-year but it has declined by 7% since the previous quarter

The P/E is 28% above the last 4 quarters average of 27.8 but 14% below the 5-year quarterly average of 41.4

The quick ratio has declined by 19% since the previous quarter

The gross margin has declined by 6% year-on-year and by 2.1% since the previous quarter

What are the main financial stats of LLY

Market
Valuations
Earnings

Shares outstanding

956.58M

Market cap

$227.55B

Enterprise value

$240.85B

Price to earnings (P/E)

35.61

Price to book (P/B)

35.4

Price to sales (P/S)

8.08

EV/EBIT

34.52

EV/EBITDA

28.6

EV/Sales

9.01

Revenue

$26.73B

EBIT

$6.98B

EBITDA

$8.42B

Free cash flow

$5.57B

Per share
Balance sheet
Liquidity

EPS

$6.68

Free cash flow per share

$6.13

Book value per share

$6.72

Revenue per share

$29.46

TBVPS

$39.61

Total assets

$47.81B

Total liabilities

$41.15B

Debt

$16.52B

Equity

$6.44B

Working capital

$2.2B

Debt to equity

2.56

Current ratio

1.15

Quick ratio

0.67

Net debt/EBITDA

1.58

Margins
Efficiency
Dividend

EBITDA margin

31.5%

Gross margin

74.3%

Net margin

22.7%

Operating margin

26.1%

Return on assets

13.1%

Return on equity

102%

Return on invested capital

19.9%

Return on capital employed

21.3%

Return on sales

26.1%

Dividend yield

1.38%

DPS

$3.29

Payout ratio

49.3%

How has the ELI LILLY stock price performed over time

Intraday

0.5%

1 week

1.68%

1 month

1.78%

1 year

62.07%

YTD

40.89%

QTD

2.96%

How have ELI LILLY's revenue and profit performed over time

Revenue

$26.73B

Gross profit

$19.85B

Operating income

$6.98B

Net income

$6.07B

Gross margin

74.3%

Net margin

22.7%

ELI LILLY's revenue has increased by 16% YoY and by 4.9% from the previous quarter

The company's gross profit rose by 10% YoY and by 2.6% QoQ

LLY's operating income is up by 9% year-on-year

The net income has grown by 8% YoY

What is ELI LILLY's growth rate over time

What is ELI LILLY stock price valuation

P/E

35.61

P/B

35.4

P/S

8.08

EV/EBIT

34.52

EV/EBITDA

28.6

EV/Sales

9.01

The P/E is 28% above the last 4 quarters average of 27.8 but 14% below the 5-year quarterly average of 41.4

The EPS has increased by 8% YoY

The equity has surged by 57% year-on-year but it has declined by 7% since the previous quarter

LLY's P/B is 53% above its 5-year quarterly average of 23.2 and 20% above its last 4 quarters average of 29.5

The stock's price to sales (P/S) is 55% more than its 5-year quarterly average of 5.2 and 22% more than its last 4 quarters average of 6.6

ELI LILLY's revenue has increased by 16% YoY and by 4.9% from the previous quarter

How efficient is ELI LILLY business performance

The company's return on equity fell by 40% YoY and by 10% QoQ

The ROS has decreased by 6% YoY and by 5% QoQ

The ROA has contracted by 6% YoY and by 3.7% from the previous quarter

What is LLY's dividend history

DPS

$3.29

Dividend yield

1.38%

Payout ratio

49.3%

Recent dividends

How did ELI LILLY financials performed over time

LLY's total assets is 16% greater than its total liabilities

The quick ratio has declined by 19% since the previous quarter

ELI LILLY's current ratio has decreased by 19% from the previous quarter and by 6% YoY

ELI LILLY's debt is 156% more than its equity

The equity has surged by 57% year-on-year but it has declined by 7% since the previous quarter

The company's debt to equity fell by 36% YoY but it rose by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.